Search Results for "vol"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for vol. Results 121 to 130 of 1447 total matches.

Patient-Controlled Analgesia

   
The Medical Letter on Drugs and Therapeutics • Nov 17, 1989  (Issue 805)
Letter, Vol. 31 (Issue 805) November 17, 1989, p. 104 Copyright  The Medical Letter UNAUTHORIZED ...
Automated intravenous delivery systems have recently become commercially available for intermittent self-administration of analgesics. Patient-controlled analgesia (PCA) has been used effectively to relieve after a wide variety of surgical procedures. It has also been effective for pain associated with labor, sickle cell crisis, and chronic pain caused by cancer.
Med Lett Drugs Ther. 1989 Nov 17;31(805):104 | Show Introduction Hide Introduction

Desmopressin for Nocturnal Enuresis

   
The Medical Letter on Drugs and Therapeutics • Apr 20, 1990  (Issue 816)
, Vol. 32 (Issue 816) April 20, 1990, pp. 38-39 Copyright  The Medical Letter UNAUTHORIZED FORWARDING ...
Desmopressin acetate (DDAVP -Rorer), a synthetic analog of the natural human antidiuretic hormone arginine vasopressin, was recently approved by the US Food and Drug Administration for treatment of primary nocturnal enuresis. DDAVP Nasal Spray, which is similar to an intranasal solution that has been available in the USA for treatment of central diabetes insipidus (Medical Letter, 20:26, 1978), will be used for the new indication.
Med Lett Drugs Ther. 1990 Apr 20;32(816):38-9 | Show Introduction Hide Introduction

Quazepam: A New Hypnotic

   
The Medical Letter on Drugs and Therapeutics • Apr 20, 1990  (Issue 816)
. As with flurazepam, daytime drowsiness occurs in some patients. The Medical Letter, Vol. 32 (Issue 816) April 20 ...
Quazepam (Doral - Baker Cummins, Wallace) is a trifluoroethyl benzodiazepine made by Schering and approved in 1985 by the US Food and Drug Administration for treatment of insomnia. Like other benzodiazepines, it is a Schedule IV controlled substance.Quazepam (Doral - Baker Cummins, Wallace) is a trifluoroethyl benzodiazepine made by Schering and approved in 1985 by the US Food and Drug Administration for treatment of insomnia. Like other benzodiazepines, it is a Schedule IV controlled substance.
Med Lett Drugs Ther. 1990 Apr 20;32(816):39-40 | Show Introduction Hide Introduction

Interleukin-2

   
The Medical Letter on Drugs and Therapeutics • Sep 07, 1990  (Issue 826)
Oncol, 7:477, 1989). The Medical Letter, Vol. 32 (Issue 826) September 7, 1990, pp. 85-86 Copyright ...
Recombinant interleukin-2 (IL-2; Proleukin - Cetus), a lymphokine that stimulates growth of T lymphocytes, is available from the National Cancer Institute on an investigational basis for treatment of renal cell carcinoma and malignant melanoma. Although recently released in many European countries, the drug has not been approved for marketing by the US Food and Drug Administration.
Med Lett Drugs Ther. 1990 Sep 7;32(826):85-6 | Show Introduction Hide Introduction

Dezocine

   
The Medical Letter on Drugs and Therapeutics • Oct 19, 1990  (Issue 829)
in nondependent drug abusers The Medical Letter, Vol. 32 (Issue 829) October 19, 1990, pp. 95-96 Copyright ...
Dezocine (Dalgan - Astra), a new synthetic opioid agonist/antagonist structurally related to pentazocine (Talwin), was recently approved for parenteral use as an analgesic by the US Food and Drug Administration.
Med Lett Drugs Ther. 1990 Oct 19;32(829):95-6 | Show Introduction Hide Introduction

Laparoscopic Cholecystectomy

   
The Medical Letter on Drugs and Therapeutics • Dec 28, 1990  (Issue 834)
or uncontrollable bleeding The Medical Letter, Vol. 32 (Issue 834) December 28, 1990, pp. 115-116 Copyright ...
Unlike new drugs, new techniques for surgery do not need the approval of any government agency. Laparoscopic cholecystectomy, made possible by the development of miniaturized television cameras, is one such technique that has recently attracted widespread interest (LW Way, N Engl J Med, 323:1273, Nov 1, 1990; R Winslow, Wall St J, 216:1, Dec 10, 1990).
Med Lett Drugs Ther. 1990 Dec 28;32(834):115-6 | Show Introduction Hide Introduction

Rabies Vaccine

   
The Medical Letter on Drugs and Therapeutics • Dec 28, 1990  (Issue 834)
and a central The Medical Letter, Vol. 32 (Issue 834) December 28, 1990, pp. 117-118 Copyright  The Medical ...
Human rabies continues to be rare in the USA, but animal rabies is becoming more common. An animal epizootic in the mid-Atlantic states, involving especially raccoons, has recently spread into the northeastern states.
Med Lett Drugs Ther. 1990 Dec 28;32(834):117-8 | Show Introduction Hide Introduction

Laser Coronary Angioplasty

   
The Medical Letter on Drugs and Therapeutics • Jan 25, 1991  (Issue 836)
system within the angioplasty balloon can relieve acute occlusion caused by The Medical Letter, Vol. 33 ...
Percutaneous transluminal coronary angioplasty (PTCA), in which a balloon catheter distends the vessel at the site of obstruction (Medical Letter, 25:97, 1983), is now an established therapeutic option for treatment of patients with coronary artery disease, especially those with single-vessel disease. Major problems related to PTCA include acute occlusion during the procedure (usually caused by dissection), restenosis at the site of angioplasty, and inability to treat complete occlusions and long or ostial lesions. Some cardiologists have tried using lasers during PTCA to deal with these...
Med Lett Drugs Ther. 1991 Jan 25;33(836):7-8 | Show Introduction Hide Introduction

Succimer - An Oral Drug for Lead Poisoning

   
The Medical Letter on Drugs and Therapeutics • Aug 09, 1991  (Issue 850)
activities have also occurred. Nasal congestion and muscle The Medical Letter, Vol. 33 (Issue 850) August 9 ...
Succimer (meso 2,3-dimercaptosuccinic acid; DMSA; CHEMET - McNeil), a heavy metal chelator, was recently marketed in the USA for oral treatment of lead poisoning in children.
Med Lett Drugs Ther. 1991 Aug 9;33(850):78 | Show Introduction Hide Introduction

Estazolam - A New Benzodiazepine Hypnotic

   
The Medical Letter on Drugs and Therapeutics • Oct 04, 1991  (Issue 854)
elderly patients. The Medical Letter, Vol. 33 (Issue 854) October 4, 1991, pp. 91-92 Copyright ...
Estazolam (ProSom - Abbott), a triazolobenzodiazepine derivative similar in structure to alprazolam (Xanax) and triazolam (Halcion), was recently marketed in the USA for treatment of insomnia.
Med Lett Drugs Ther. 1991 Oct 4;33(854):91-2 | Show Introduction Hide Introduction